It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
A high technical success rate (97%) and low complication rate were observed. Exercise performance and health-related QOL results improved significantly after stent placement.
Our experience provides some evidence that early mortality of life-threatening acute type B aortic dissection may be reduced by emergency endovascular stent grafting and that this form of treatment is a promising therapeutic option.
1. Inappropriate use of stents can be dangerous, and sometimes, deadly.
Originally posted by bsl4doc
1. Inappropriate use of stents can be dangerous, and sometimes, deadly.
...Most doctors (I say most because there are always those who temper their judgement with $$, but I feel they are in the minority, despite your undocumented claims to the contrary)
Doctors Rethink Widespread Use of Heart Stents
The medical community is having second thoughts about stents. ...stents are a big business, generating $6 billion a year in sales for their makers and thousands of dollars in fees for each procedure performed by the specialists implanting them.
...But now ...some doctors are rethinking their faith in the devices, driven by emerging evidence that the newest and most common type — drug-coated stents — can sometimes cause potentially fatal blood clots months or even years after they are implanted.
Stem Cell Experiment Yields Heart Valves
Scientists for the first time have grown human heart valves using stem cells from the fluid that cushions babies in the womb, offering an approach that may be used to repair defective hearts.
The idea is to create new valves in the laboratory while a pregnancy progresses and have them ready to implant in a baby with heart defects after it is born.
The Swiss experiment follows recent successes at growing bladders and blood vessels and suggests that people may one day be able to grow their own replacement heart parts, in some cases, even before they are born.
Pathology of in-stent restenosis.
The process of in-stent restenosis parallels wound healing responses. Stent deployment results in early thrombus deposition and acute inflammation, granulation tissue development, and ultimately smooth muscle cell proliferation and extracellular matrix synthesis. The severity of arterial injury during stent placement correlates with increased inflammation and late neointimal growth. These pathological findings provide useful targets for therapies aimed at reducing the incidence of in-stent restenosis.
Angioplasty and Stenting Useless, Possibly Dangerous, 12 Hours After Heart Attack
Opening a blocked artery with balloons and stents can be lifesaving in the early hours after a heart attack, but a new study concludes that it often does no good if the heart attack occurred three or more days before. ...The new study “should change practice, and I believe it will,” said Dr. Judith S. Hochman, director of the cardiovascular clinical research center at New York University medical school, and leader of the study, which included 2,166 patients at 217 hospitals in the United States and other countries.
Stents have been increasingly used in people with clogged arteries who are not having heart attacks, but some studies suggest that those patients would be better off taking drugs to reduce cholesterol, inflammation and clotting. The reasoning is that artery disease tends to be systemic and extensive, but stents can treat it only in tiny spots.
***
A standard treatment for heart artery blockages has now been shown to increase the risk of fatal blood clots. ...Drug coated stents, which are little mesh tubes used to prop open clogged heart arteries, are used in more than 90 percent of stent procedures. (BUT)... The evidence suggests drug-eluting stents may be beneficial in only a third of patients. Some experts believe they should be used primarily in small blood vessels, where the risk of restenosis is greatest.
"We sort of can't just stent everyone with a drug eluting stent with impunity like we thought," Dr. Finkielstein said, "that being said, there is going to be a high risk patient who will benefit from drug eluting stents, certainly the technology is good and we just need to find which patients would benefit."
The stent market is worth more than $5 billion a year. Coated stents cost around three times more than bare metal ones.
***
The FDA said today it will hold a special meeting of a device advisory committee to assess new data about "small but significant" increases in the rates of death and myocardial infarction among patients treated with drug-eluting coronary stents.
...the FDA said that for "thousands of patients each year, these devices have resulted in a significant reduction in the need of second procedures to treat restenosis." An estimated one million drug-eluting stents have been implanted in patients in the United States.
***
The safety of drug-eluting stents in patients with coronary artery disease has been called into question following the presentation of 2 independent meta-analyses here at the European Society of Cardiology World Congress of Cardiology (WCC). ... The studies, which were reported at a Hotline session on September 3rd, sparked alarm and controversy by suggesting that drug-eluting stents carry a higher risk of death and myocardial infarction (MI) than traditional bare-metal stents. ...the new studies, which pooled data from randomized controlled trials involving first-generation sirolimus- or paclitaxel-coated stents, revealed increased rates of stent thrombosis leading to death or Q-wave MI, as well as increased rates of non-cardiac death.
Edoardo Camenzind, MD, cardiologist, University Hospital, Geneva, Switzerland, and colleagues found that rates of death or MI during extended follow-up were 30% to 40% higher in patients who received the Cypher sirolimus-coated stent than in those with bare-metal stents. ...Dr. Camenzind's analysis evaluated data from the Randomized Study with the Sirolimus-eluting Velocity Balloon-Expandable Stent, Sirolimus-Eluting Stent in De Novo Native Coronary Lesions (SIRIUS), European-SIRIUS, and Canadian-SIRIUS studies. Data were analyzed at 4 different time points for each type of stent.
In a second study, Alain Nordmann, MD, clinical epidemiologist, Basel Institute for Clinical Epidemiology, University Hospital, Basel, Switzerland, and colleagues combined data from 17 trials of drug-eluting stents with follow-up periods of 1 to 4 years. ...Dr. Nordmann's analysis found a greater than 2-fold increase in the rate of non-cardiac death in patients who received sirolimus-coated stents versus controls. Causes of death included cancer, stroke, and lung disease.
Studies Link Drug-Eluting Stents With Death, Myocardial Infarction: Presented at WCC
Originally posted by bsl4doc
I agree that there needs to be more transparency in the American medical institution,
I see no reason stents should be removed altogether.
I think that they, like ANY OTHER NEW MEDICATION/TREATMENT/TECHNIQUE, can only be studied and evaluated once in use. ...Until we meet these problems head on and reevaluate the treatment's usage, there will always be high numbers of complications.
You are advocating the use of patients as guinea pigs. I don't support that.
Please read the PubMed article on restenosis linked above. FYI - The restenosis "problem" can be "predicted" by a few protein tests. Which are NOT routine because the underlying 'vascular' disease is epidemic, and the tests are positive too often.
Originally posted by soficrow
Again -
The real issue here is that stents went from obscurity to mass-use in a few short years - with no transparency or sharing of data. There were and are significant problems arising from inappropriate use.
The big brouhaha is about protecting a $6 BILLION industry - not patients' rights to appropriate care.
Originally posted by soficrow
This thread is about the dangers of inappropriate stenting, not the pros and cons of "capitalism."
As I pointed out and clarified:
The FDA and EU are considering new stent guidelines - to protect patients.
That's not a bad thing, imo.
...I certainly hope everyone can see past the marketing campaigns, and the people who push the marketing propaganda for questionable purposes.
Originally posted by bsl4doc
Again, what exactly do you have a problem with?
Originally posted by soficrow
Originally posted by bsl4doc
Again, what exactly do you have a problem with?
Please, read the posts for more information.
And please, stop trying to derail this thread.
Your sympathies with industry are obvious, and you appear intent on to sabotaging fruitful discussion and the open sharing of information. If that is not your intent, you might consider changing your tactics.
.
Originally posted by D4rk Kn1ght
Sofi, I'm sorry, but you are entitled to your opinion, how ever alarmist it may be, but the truth of the matter is, stents save lives.
You want to be looked after in a capitalist society, yet bitch and moan when a company tries to save lives and make a dollar at the same time......
Are you saying people ought to happily give their lives so their local stent salesmen can meet his quota?
Originally posted by bsl4doc
Are you saying people ought to happily give their lives so their local stent salesmen can meet his quota?
The "stent salesman" doesn't prescribe the treatment, and believe it or not, most doctors are not out to screw you.
Perhaps you could come down off of your pedestal and see that doctors aren't angels of death in white coats?
Doctors Rethink Widespread Use of Heart Stents
. ...stents are a big business, generating $6 billion a year in sales for their makers and thousands of dollars in fees for each procedure performed by the specialists implanting them.
...some doctors are rethinking their faith in the devices, driven by emerging evidence that the newest and most common type — drug-coated stents — can sometimes cause potentially fatal blood clots months or even years after they are implanted.
The issue is that stents are being marketing aggressively, used inappropriately - and are killing people because of that abuse.
Stents are NOT for everyone - studies show they likely are most useful as an emergency intervention in life threatening situations when other therapies do not work.
Stents went from obscurity to mass-use in a few short years - with no transparency or sharing of data. There is no transparency, accountability or independent analysis of trial data for medical devices like stents.
You focus on protecting a $6 BILLION industry - not patients' rights to appropriate care.
Unlike you, some doctors are having second thoughts about stents - because of the new data.
...some doctors are rethinking their faith in the devices, driven by emerging evidence that the newest and most common type — drug-coated stents — can sometimes cause potentially fatal blood clots months or even years after they are implanted.
Quite simply - stents are not for everyone. But they are marketed as if they are, and have been used as if they are.
People have died as a result of this marketing campaign. Unless someone puts on the brakes, more people will die, needlessly. Others will just waste their money on unnecessary, risky surgery - money better spent elsewhere.